Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

5-LO inhibitor approved by FDA

Dec. 13, 1996

First approval for Pharmacyclics' MRI contrast agent

Dec. 12, 1996

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

OsmoCyte approved for marketing in U.S.

Dec. 9, 1996

Cytovene approved for new indication in U.S.

Dec. 6, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

First approval for Aricept

Nov. 27, 1996

Water-soluble fiber introduced in first market for high cholesterol

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...